Publications by authors named "Xoan Carlos Sanmartin-Pena"
Aim: The relative apical sparing pattern of left ventricular (LV) longitudinal strain (RELAPS]>1) has been described as a typical sign of cardiac amyloidosis (CA). The objective was to validate this pattern in concomitant CA and aortic stenosis (AS) and to identify new echocardiographic variables suggestive of CA in the presence of AS.
Methods And Results: 324 consecutive patients (age 81.
Background: Limited data are available regarding change in the nutritional status after transcatheter aortic valve replacement (TAVR). This study evaluated the prognostic impact of the change in the geriatric nutritional risk index following TAVR.
Methods: TAVR patients were analyzed in a prospective and observational study.
Background: Healthcare systems are under prominent stress due to the COVID-19 pandemic. A fast and simple triage is mandatory to screen patients who will benefit from early hospitalization, from those that can be managed as outpatients. There is a lack of all-comers scores, and no score has been proposed for western-world population.
View Article and Find Full Text PDFArticle Synopsis
- COVID-19 is a global pandemic, and researchers aimed to understand if prior use of ACE inhibitors (ACEI) or angiotensin receptor blockers (ARB) affects the outcomes for patients diagnosed with the virus.
- A retrospective study of nearly 1,000 COVID-19 patients found that those on ACEI/ARB drugs showed no significant differences in mortality, hospitalization, or severe cardiovascular events.
- The study concludes that continuing ACEI/ARB treatment in COVID-19 patients is supported by existing guidelines, as it doesn't negatively impact their health outcomes.
Introduction And Objectives: Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection.
View Article and Find Full Text PDFBackground: Coronavirus disease-2019 (COVID-19) is caused by severe acute respiratory-syndrome coronavirus-2 that interfaces with the renin-angiotensin-aldosterone system (RAAS) through angiotensin-converting enzyme 2. This interaction has been proposed as a potential risk factor in patients treated with RAAS inhibitors.
Objectives: This study analyzed whether RAAS inhibitors modify the risk for COVID-19.
Coronary artery disease (CAD) is a common co-morbidity in transcatheter aortic valve implantation (TAVI) patients, but the prognostic value of coronary revascularization before TAVI is currently unknown. The aim of the present study was to assess the impact of coronary revascularization in patients who underwent TAVI. Patients underwent TAVI from 2008 to 2016 were included in the study.
View Article and Find Full Text PDF